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Abstract
Asperger Syndrome (AS) is a neurodevelopmental condition characterized by impairments
in social interaction and communication, alongside the presence of unusually repetitive,
restricted interests and stereotyped behaviour. Individuals with AS have no delay in cogni-
tive and language development. It is a subset of Autism Spectrum Conditions (ASC),
which are highly heritable and has a population prevalence of approximately 1%. Few
studies have investigated the genetic basis of AS. To address this gap in the literature,
we performed a genome-wide pooled DNA association study to identify candidate loci in
612 individuals (294 cases and 318 controls) of Caucasian ancestry, using the Affymetrix
GeneChip Human Mapping version 6.0 array. We identified 11 SNPs that had a p-value
below 1x10-5. These SNPs were independently genotyped in the same sample. Three of
the SNPs (rs1268055, rs7785891 and rs2782448) were nominally significant, though none
remained significant after Bonferroni correction. Two of our top three SNPs (rs7785891
and rs2782448) lie in loci previously implicated in ASC. However, investigation of the three
SNPs in the ASC genome-wide association dataset from the Psychiatric Genomics Consor-
tium indicated that these three SNPs were not significantly associated with ASC. The effect
sizes of the variants were modest, indicating that our study was not sufficiently powered to
identify causal variants with precision.
Introduction
Asperger Syndrome (AS) is a neurodevelopmental condition and a subset of Autism Spectrum
Conditions (ASC) [1]. Individuals with ASC have difficulties in social interaction and
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communication, alongside unusually repetitive and stereotyped behaviour and unusually nar-
row interests. In AS, language and cognitive development proceed on time. ASC is highly heri-
table [2], with monozygotic twin heritability rate estimated between 73 – 95% [3], and has a
prevalence of approximately 1% [4]. ASC is characterized by high clinical and aetiological het-
erogeneity. Environmental, epigenetic and genetic factors have been implicated in ASC [3, 5–
7]. Currently, more than 660 genes are implicated in ASC (https://gene.sfari.org/autdb/HG_
Home.do), though no single gene or variant accounts for more than 1–2% of cases [5,8]. Addi-
tionally, several large copy number variants that duplicate or delete multiple genes have also
been identified in association with ASC [3,9].
Though no common variant has been consistently associated with ASC across multiple
Genome-wide Association Studies (GWAS) [3,5], it is clear now that they contribute consider-
ably to the variation in ASC [10, 11]. Two recent studies have identified that common inherited
variation contributes to between 40 – 60% of the variance in ASC [10, 11]. However, despite
the majority of variance attributable to common inherited variants, as explained earlier,
genome-wide association studies have failed to consistently identify causative variations. One
explanation for this lack of success is that genome-wide association studies in ASC may be
underpowered to detect small effect sizes; the largest ASC GWAS had less than 9000 partici-
pants (cases and controls) and, although this seems large, it has been argued that much larger
sample sizes are needed (in the range of tens and hundreds of thousands) to successfully iden-
tify causative variants [9]. An alternative view is that the inability to consistently identify causa-
tive common variants is due to the underlying genetic and phenotypic heterogeneity. At a
phenotypic level, delay and difficulties in language development is an important source of het-
erogeneity in ASC. Language delay in individuals with ASC is associated in changes in brain
volume in both total grey matter and in specific regions in the brain [12]. This different brain
architecture points to different biological and genetic networks involved in different forms of
ASC. As mentioned earlier, AS is a subset of ASC where individuals have no language delay,
suggesting it may have a genetic architecture distinct from the rest of ASC.
Only a few studies have specifically investigated the genetics of AS. In one of the first such
studies, we tested for associations between 216 SNPs across 68 candidate genes. We identified
nominal associations between SNPs in 14 genes and AS [13]. In the current study, we per-
formed a pooled DNA genome wide association in individuals with AS and controls to identify
SNPs in a hypothesis-free way. DNA pooling is a rapid, efficient and economical method to
identify genetic associations in various conditions [14]. We hypothesized that genome-wide
DNA pooling would detect the differences in allele frequencies between individuals with AS
and controls. SNPs whose p-values were below a pre-defined threshold were then individually
genotyped in the same sample using an established approach reported in several previous stud-
ies [15–17].
Methods
Participants
612 individuals were genotyped in the pooled genotyping stage. There were 294 cases
(males = 254, females = 40, reflecting the male bias in AS [5]) and 318 controls (males = 250,
females = 68). 607 of these individuals were individually genotyped. 5 (1 case and 4 controls)
individuals were not genotyped at this stage due to poor DNA quality. All participants reported
Caucasian ancestry for at least 2 generations. All cases were recruited from the Cambridge
Autism Research Database (CARD) at www.autismresearchcentre.com, and reported that they
had a clinical diagnosis of AS according to DSM IV or ICD-10 criteria. Clinical diagnostic
assessment was done by independent clinicians. Control participants were recruited through
AS Pooled GWAS
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advertisement and reported that they were free of psychiatric and neurological conditions.
Written consent was obtained from all participants. Ethical approval was obtained from the
National Health Service Research Ethics Service (NRES).
Pooled DNA Genotyping
DNA from each participant was extracted from buccal swabs and anonymized. DNA was then
suspended in Tris-EDTA and quantified using PicoGreen double-stranded DNA quantifica-
tion reagent (Invitrogen, USA). 100 ng of DNA from each individual was added to their respec-
tive pool. The cases were divided into 7 pools with 5 pools for males and 2 pools for females.
On average, there were 42 participants in each pool, though the numbers ranged from 12 to 59.
Two additional pools with 24 female cases and 44 male cases were genotyped, but were not
included in the analysis or taken forward for individual genotyping due to DNA contamina-
tion. The controls were divided into 9 pools with an average of 35 participants per pool. The
number of participants per control pool ranged from 14 participants to 57.
Genotyping was performed using the Affymetrix GeneChip Human Mapping version 6.0
array (Affymetrix, California, USA) according to the protocol recommended by the company.
Cell intensity (.cel) files were generated using GeneChip Scanner 3000 7g. The files generated
were converted into relative allele signal scores (RAS) using a custom made script (snpmap.R
[18]).
To test for differences in allele frequencies for each SNP between the cases and the controls,
independent t-tests (equal variance assumed) were performed using the mean RAS scores from
the pools. In addition, Levene’s test was performed to check for equality of variance. A thresh-
old of significance was chosen a priori at p = 1 x 10−5. This particular threshold was chosen in
order to reduce the risk of false negatives due to the loss of power from DNA pooling [19] and
this is a threshold that is typically used in the discovery phase of GWAS studies. All SNPs were
screened for quality control. The study design had approximately 38% power to detect variants
with an effect of 1.3 for the given threshold of significance after taking power loss due to DNA
pooling into consideration. The frequency of both the marker and the effect allele was 0.5 for
the power calculation. SNPs were rejected if they had a minor allele frequency (MAF) below
0.01 in the Caucasian population according to the HapMap project, and if the coefficient of
variation (calculated as SD/mean) in more than 50% of the pool was greater than 0.2. All SNPs
which passed quality control and had a p-value below the threshold of significance were taken
forward for individual genotyping to verify the result from the pooled association. Nominally
significant SNPs in the individual genotyping stage were further investigated using summary
genome-wide association data of the ASC cohort available from the Psychiatric Genomics Con-
sortium (PGC, http://www.med.unc.edu/pgc/). The PGC analysed genome-wide SNPs using
DNA from 161 cases, 526 controls, 4788 trio cases and 4788 trio pseudocontrols, all of Cauca-
sian ancestry. A crucial difference in the PGC cohort from our study cohort is that the PGC
cohort did not stratify for language delay (and hence includes cases of autistic disorder/child-
hood autism as well as AS). Additional details of methods, statistical analyses and participant
ancestry are provided elsewhere [20].
Individual Genotyping and functional annotation
Individual genotyping was performed by Geneservices UK Ltd using the SequenomMassAR-
RAY iPLEX platform (Sequenom, San Diego, USA). 5 (1 case and 4 controls) individuals who
were genotyped at the pooled DNA analysis stage were not included in this stage due to poor
DNA quality. Total genotyping rate was 97%. MAF in the genotyped sample for all the SNPs
was above 0.05. Allelic association testing was performed using Plink v1.07 (http://pngu.mgh.
AS Pooled GWAS
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harvard.edu/~purcell/plink/) [21]. Functional annotation was performed using Haploreg v2
(http://www.broadinstitute.org/mammals/haploreg/) [22] and SNPnexus (http://www.snp-
nexus.org/) [23].
Validation of DNA pooling and replication
To assess the accuracy of DNA pooling in predicting differences in allele frequency, we individ-
ually genotyped 12 random SNPs in all the participants. This includes 11 SNPs that did not
reach the predefined threshold in the pooled association stage and one SNP, rs7785891, which
did reach the threshold. Pearson’s correlation coefficient between the mean RAS scores and the
allele frequency was calculated at r = 0.65. This correlation is considerably higher than another
study that used pooled DNA obtained from cheek swabs on the same platform, though lower
than the correlation reported for DNA obtained from blood samples [24].
Results
In the DNA-pooling stage, 11 SNPS passed the threshold of significance and quality control.
Additionally, 5 SNPs with p-values below 1 x 10−5 failed quality control at the pooling stage
(Fig 1). All the 11 SNPs were individually genotyped and all the SNPs passed quality control in
the individual genotyping phase. Three SNPs were nominally significant at p<0.05 in this
stage (rs7785891, rs1268055, and rs2782448). None of the SNPs survived correction for multi-
ple testing using Bonferroni correction. None of these three nominally significant SNPs from
the individual genotyping stage were significant in the PGC ASC dataset. Results are summa-
rised in Table 1. A Q-Q plot of the results from the pooling stage is provided in Fig 2.
Discussion
The current study used pooled DNA analysis to identify common variants associated with AS.
Using pooled DNA we scanned the genome for SNPs that had a difference in allele frequencies
between the case groups and the control groups. A threshold of 1 x 10−5 was selected in the
pooling stage due to the loss of power during DNA pooling and to control for false negatives.
SNPs which had p-values below the pre-defined threshold were treated as candidate SNPs and
genotyped individually in the same group of individuals to more accurately estimate allele fre-
quencies. Of the 11 SNPs that crossed the threshold of significance in the pooling stage, only
three remained nominally significant after the individual genotyping stage. These three SNPs
were not significantly associated with ASC in a larger, more heterogeneous ASC cohort from
the PGC consortium.
rs778589, the top performing SNP at the pooling stage, is an intronic SNP in DOCK4, a
gene previously associated with ASC [25, 26]. rs2782448 is an intergenic SNP at 13q21. It is
Fig 1. Manhattan plot of the SNPs tested in the pooled DNA association stage.
doi:10.1371/journal.pone.0131202.g001
AS Pooled GWAS
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371 kb from KLHL1 and 7.5 kb from the 3’ end of RP11- 459J23.1, a LincRNA identified by the
Gencode project. 13q21 has been previously implicated in both autism [27, 28] and Specific
Language Impairment [29]. The third nominally significant SNP, rs1268055, is an intronic
SNP in ARMC2, a gene with uncertain function in humans.
The major limitation of this study is power. First, DNA pooling retains only 68% percent of
the power [19]. Second, even after only selecting for individuals with AS, no SNP remained sig-
nificant after Bonferroni correction. This indicates that larger sample sizes are required to
detect causative alleles of small effect sizes. There is a considerably high correlation between
the two stages of analysis, yet of the eleven SNPs selected for individual genotyping, only three
remained nominally significant at this stage. The top two associated SNPs that passed quality
control in the pooled DNA analysis stage were both nominally significant at the individual gen-
otyping stage. However, they did not remain significant after correction for multiple compari-
sons. Of the three nominally significant alleles, rs7785891 has an odds ratio above 1, whereas
rs1268055 and rs2782448 have odds ratio below 1 (see Table 1). Finally, while all our partici-
pants reported Caucasian ancestry for at least two generations, population stratification can
confound the results and lead to false positives [30]. There are currently no known methods to
correct for population stratification for pooled DNA association studies, taking into account
the polygenicity of the condition.
Table 1. Summary of results.
RSID Chr Closest Gene P-value
(pooled
genotyping)
P-value
(individual
genotyping)
Allele 1
(minor
allele)
Freq of
allele 1
Allele 2
(major
allele)
Freq of
allele 2
Chi-Sq Odds
Ratio
P-value
(PGC
cohort)
rs2782448 13 KLHL1 5.32759E-06 0.005566 G 0.2872 C 0.7128 7.686 0.7075 0.4867
rs1268055 6 ARMC2 1.49962E-06 0.03515 G 0.4468 A 0.5532 4.438 0.782 0.3917
rs7785891 7 ZNF277/DOCK4 3.27832E-08 0.04701 G 0.4094 C 0.5906 3.945 1.268 0.4532
rs25870 5 FSTL4 3.23677E-06 0.09446 C 0.2555 T 0.7445 2.797 0.8021 NA
rs7826102 8 CSMD1
/LOC100287015
2.73904E-06 0.1654 G 0.09464 C 0.90536 1.924 0.7685 NA
rs4665507 2 LOC645949 /
KLHL29
4.00377E-06 0.5449 G 0.1098 A 0.8902 0.3665 0.8959 NA
rs7047415 9 PTCH1
/LINC00476
4.41161E-06 0.576 T 0.1036 C 0.8964 0.3127 1.116 NA
rs11901152 2 NRXN1 / ASB3 / 9.99301E-06 0.4843 A 0.2927 G 0.7073 0.4892 0.9155 NA
rs1036557 8 CSMD1 7.96515E-06 0.5411 G 0.4173 C 0.5827 0.3735 0.9298 NA
rs13005010 2 ITGA6 6.31853E-06 0.2523 A 0.113 G 0.887 1.31 1.249 NA
rs1526483 7 SEMA3A 3.40181E-06 0.908 G 0.1232 A 0.8768 0.01336 0.9796 NA
doi:10.1371/journal.pone.0131202.t001
Fig 2. Quantile-quantile plot of the SNPs tested in the pooled DNA association stage.
doi:10.1371/journal.pone.0131202.g002
AS Pooled GWAS
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While the current study tested for association with AS, we also checked to see if the three
nominally significant SNPs were significant in an ASC cohort. The direction of effect for all
three SNPs was similar to the effect direction in our sample. However, none of the three SNPs
were nominally significant in the PGC ASC cohort. This may be due to a) the heterogeneity of
the PGC cohort compared to our study cohort, since the former did not stratify for language
delay, and/or b) the design of the association study being different (a family based association
study based on trios vs a population based study), which may lead to different signal-to-noise
ratios. However, it needs to be highlighted that the effect sizes for the SNPs in both the samples
were small. This underscores the need for larger sample sizes to effectively identify common
variants.
In conclusion, we report the identification three SNPs (rs1268055, rs7785891 and
rs2782448) as nominally associated with AS using a genome-wide pooled DNA association
study. rs2782448 and rs1268055 lie in genetic loci previously implicated in ASC. None of the
SNPs remained significant after Bonferroni correction, underscoring the need for larger sample
sizes to uncover alleles with small effect sizes. This is the first genome-wide case-control associ-
ation study to test common variants for association with AS.
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